Sherry Hsieh

Staff Reporter

Email: hsieh@ocbj.com
Phone: 949-833-8373 Extension: 242

Recent Stories

Nemus Raises $1.75M

Nemus Bioscience Inc. (OTCQB: NMUS) received a $1.75 million private placement from majority shareholder Emerald Health Sciences Inc. and other investors.

Tease photo

Top Care Providers Experience Exec-Level Change

UCI to Fill Two Positions; Providence Taps New Head

High performers like UC Irvine Medical Center and Providence St. Joseph Health—its local network comprised of seven hospitals—experienced changes on the executive level in the year ended Sept. 30, the former in search of a new chief executive, the latter naming a regional head to oversee Los Angeles, Orange and San Bernardino counties.

Q&A

If there’s one word to describe the nation’s healthcare industry it’s uncertainty. The new tax bill repealed the Affordable Care Act’s individual mandate provisions that required most Americans to purchase health insurance or face penalty, which could hurt hospital revenue with fewer people buying health plans. The bill also took away nonprofit hospitals’ ability to use advanced refunding to replace outstanding bonds with bonds at lower interest rates.

MYnd Analytics Expands Technology Scope

Nondrug Therapy TMS Targets Depression

Mission Viejo-based MYnd Analytics Inc. (Nasdaq: MYND) is in the business of behavioral health.

Flu Patient Volume Uptick During Holiday Season

Hospitals Up Game To Better Coordinate Care

It was the worst of times and the worst timing. “The uptick in flu cases in mid-December spiked around Christmas and New Year’s Eve, around the holidays, a lot of traveling and socializing with family and friends,” said Dr. Wendy Coling, a Kaiser Permanente primary care physician in Orange County. She said it didn’t help that this year’s H3N2 influenza virus is a “more virulent flu strain.”

Online Lender SpringboardAuto to Double Headcount

Irvine-Based Company Grows With New Office

SpringboardAuto, an Irvine-based online direct lender that connects customers with auto lenders, has doubled its office size and now plans to double its employee count to 100 by the end of the year.

Health Software Co. Tagnos Lands $5M Series A

Technology Gains Traction With Reimbursement Change

There are plenty of opportunities for software solutions in healthcare operations, ranging from medical-records management to analytics to compliance.

Digital Tools Grow as Patient-Engagement Evolves

Include Monitoring, More Access to Care on Demand

Digital health is the buzzword when it comes to the present and the future of care. Technologies, such as telemedicine, remote patient monitoring and patient engagement via smartphones, are designed to enable providers and patients to manage health and wellness more effectively and cost-efficiently.

Sanitization Firm GermFalcon Wins NASA Contest

Ready to Roll Out Device, Says First Order in March

Given the particularly bad flu season (see related story, page 26), GermFalcon’s germ-killing device is well-timed. The device uses ultraviolet-C light, the kind used in hospitals, to disinfect airplane cabins.

Avid Expects $20M from Secondary Offering

Tustin-based Avid Bioservices Inc. yesterday priced a public offering of 9 million shares of common stock at $2.25 apiece, and expects more than $20 million in gross proceeds after the offering closes next week.

Tease photo

Avid Sells Oncology Drug

Avid Bioservices Inc. in Tustin will sell its clinical-stage immunotherapy cancer drug candidate to Oncologie Inc. for $8 million upfront—with payments spread over six months—and up to $95 million in development, regulatory and commercialization milestones.

Tease photo

Device Maker Masimo Starts Year on Strong Note

Got European, US Clearances, Stock Uptick

January was a busy month for Irvine-based patient monitoring device maker Masimo Corp., which announced Food and Drug Administration approval of two devices.

Service Provider Concerto Grows

HEALTHCARE: New Aliso Viejo HQ; hiring 120

A primary care doctor is the first stop for a patient’s medical care, including chronic disease management.

J&J-Backed ReVision Optics Closes

Lake Forest-based ReVision Optics Inc. has shut down saying, “it is with regret, that we have to close our doors.”

Tease photo

Evolus Prices IPO

Irvine-based Evolus Inc. priced its initial public offering of five million shares of common stock at $12 per share, the low end of an earlier-announced $12 to $14 range.

Tease photo

UCI's Federoff Resigns Health Post

University of California-Irvine accepted the resignation of Howard Federoff, vice chancellor of health affairs and chief executive of UCI Health System.

Tease photo

Allergan Q4 Strong

Allergan PLC reported strong fourth-quarter revenue of $4.3 billion, up 12% from a year earlier, and full-year revenue of nearly $16 billion, a 9.4% increase.

Tease photo

Allergan Appoints CFO

Allergan PLC named Matthew Walsh chief financial officer, effective “later this month.”

Tease photo

Edwards to Build on Strong Q4

Edwards Lifesciences Corp. finished the year strong, reporting $889 million in fourth-quarter sales, up 16% from a year earlier.

Tease photo

Bonti Bets Big on Therapeutic Botox

HEALTHCARE: Adds scar therapy after new $15.5M round

Newport Beach-based Bonti is developing its own Botox. But unlike other competitors that aim to directly compete with Allergan PLC, it’s focusing on expanding therapeutic use of its lead neurotoxin candidate, EB-001.

Concierge Key Launches Fast Pass of Healthcare

First Three Regions: Orange County, New York, Phoenix

Paying for special perks isn’t new in healthcare.

Aerie Gets $74M Offering to Market Eye Drugs

Strategy Also Includes New Manufacturing Plant

The outlook for Aerie Pharmaceuticals Inc.’s (Nasdaq: AERI) two glaucoma drugs appears to be good—Rhopressa received Food and Drug Administration approval in December, and the company said its other late clinical-stage drug, Roclatan, is on track for approval in the second quarter.

Aerie Offering Comes in at $74M

Aerie Pharmaceuticals Inc. sold 1.3 million shares of common stock for $74 million.

Tease photo

Toyota Grabs Joystick With Blizzard Esports Deal

Partnership Helps It Build ‘Premium Experience’

Toyota Motor North America signed on as North American Launch Partner of Blizzard Entertainment Inc.’s Overwatch League, a professional video gaming competition with esports franchises in Boston, London, Los Angeles, Miami-Orlando, New York, San Francisco, Seoul and Shanghai.

Mission Hospital Grows With Partners

HEALTHCARE: Cancer center under construction; opens 2019

Take a hospital and a shopping mall owner, and what do you get? A retail experience that combines shopping, dining and healthcare.

J&J Device Co. Biosense Webster Enrolls Patients

To Study if WaveCrest Reduces Stroke Risk

Arrhythmia is an abnormal heart rhythm leading to heartbeats that are too slow, too fast or irregular.

Bonti Lands $15.5 Million Series C

Newport Beach-based Bonti closed $15.5 million in series C financing.

Tease photo

Providence St. Joe SoCal Head Talks 2018 Agenda

14-Person Team To Lead Regional Strategy

In Orange County, Providence St. Joseph Health has more of a local flavor—its local presence is best known as St. Joseph Hoag.

Supplement Maker Broadens Its Footprint in Asia

Company Launches Products in Singapore

Supplement maker ChromaDex Corp.’s rapid expansion in Asia speaks to the importance of choosing the right type of investors.

From One Eye to Another: Aerie Gets Ex-Allergan Exec

Medical Affairs Head To Help Launch Drug

The latter half of last year was busy for Aerie Pharmaceuticals Inc. The Irvine-based ophthalmic company ramped up operations, adding staff in research and development, commercialization and business development in preparation for Food and Drug Administration approval of glaucoma drug Rhopressa.

New York Car Care Product Maker Makes OC Home

Irvine Location To Be West Coast HQ

Third time’s a charm for Automotive Care Laboratories LLC.

Alphaeon Subsidiary Files for $75M IPO

HEALTHCARE: Late-stage alt-Botox in need of fresh capital

Evolus Inc. has some good news and some bad news.

Tease photo

Expanding in OC

Office Space Provider Gung-Ho About Growth

WeWork Spectrum Center buzzed with energy. The space, brightly lit and colorful—modeled after Wes Anderson’s film “The Grand Budapest Hotel”—represents the epitome of flexible, noncommittal office concepts where laptops move freely from communal tables to individual workstations or private offices, and collaborations can happen over a conversation at the coffee station.

Tease photo

Skin Tightening Device Maker Claims OC Home

HEALTHCARE: Recros lands $9M; foresees 2019 launch

Aesthetic device maker Recros Medica Inc. in San Diego plans to strengthen clinical and commercial efforts with a recently closed $9 million financing, and it’s bringing it all to Orange County.

Providence St. Joseph’s Wexler Fills Out Team

Providence St. Joseph Health Southern California Chief Executive Erik Wexler named most of an executive team to oversee 14 hospitals in Orange County, and Los Angeles and San Bernardino counties.

Tease photo

Botox Competitor Files for IPO

Evolus Inc. plans an IPO of up to $75 million, according to documents filed with the SEC Tuesday.

Tease photo

Allergan Cuts 1,000 Jobs With Likely Loss of Restasis

Generic Brands Could Enter Market This Year

Allergan PLC, which had a rough year following its controversial patent transfer deal with a Native American tribe, said it will cut over 1,000 jobs in preparation for losing patent exclusivity for blockbuster dry-eye drug Restasis.

Local Firms Hot For Foreign Investors

HEALTHCARE: Japan, Korea, China aggressive with gov. help

It’s no news that there’s a growing senior population.

Peregrine Changes Name

Tustin-based Peregrine Pharmaceutical Inc. changed its name to Avid Bioservices Inc., now that it’s a dedicated contract development and manufacturing organization.

Tease photo

Supplement Maker Targets Girls’ Concussion Risk

Product Claims Protection for Brain

Newport Biosciences LLC Chief Executive Thomas Kinder isn’t new to the dietary supplement space; he previously launched brands that target migraines and micronutrient deficiencies in post-bariatric surgery patients.

Local Ophthalmic Companies Aim for FDA Nod

Aerie Well On Track; Presbia Changes Strategy

Ophthalmic companies Aerie Pharmaceuticals Inc. (NASDAQ: AERI) and Presbia PLC (NASDAQ: LENS) are pursuing Food and Drug Administration approval of their drugs and device, respectively.

BPOY 2017 Healthcare: Charles Dunlop

Laguna Native Couldn’t Have Mapped Better 2017

It’s hard to put a label on Charles Dunlop, founder and president of Ambry Genetics Corp. He is, in his own words, a “lab tech” who derives more joy from working in labs, yet he speaks with the boldness of a visionary when he says his main goal isn’t to cure a particular disease but all diseases.

Tease photo

Sonendo Gets CFO

Sonendo Inc. appointed Michael Watts chief financial officer.

Tease photo

Presbia Cuts Back; Execs Resign

Presbia PLC’s executive chairman and chief executive have resigned and the eye care device maker said it would cut expenses as it considers a $5 million investment from an affiliate of its majority shareholder.

Tease photo

Another Top Executive Leaves Allergan

Allergan PLC (NYSE: AGN) Chief Operating Officer Robert Stewart will resign to become president and chief executive officer of Amneal Pharmaceuticals LLC starting January 25, according to filings with the Securities and Exchange Commission.

Tease photo

Aerie Gets Early FDA OK

Irvine-based Aerie Pharmaceuticals received Food and Drug Administration approval for its glaucoma eye drop Rhopressa two months ahead of an informal goal date in February.

Tease photo

MemorialCare in Imaging Center JV

MemorialCare in Fountain Valley formed a joint venture, to start Jan. 1, with L.A.-based Radnet Inc., an outpatient imaging center operator.

Tease photo

Spectrum Pharma Swaps Out CEO

Spectrum Pharmaceuticals Inc. said its board dismissed its Chief Executive Rajesh Shrotriya without cause in accordance with Shrotriya’s agreement with the company, effective immediately.

Tease photo

AiVita Advances on Clinical, Commercial Pipelines

Enrolled First Patient; Launched Beauty Line

Irvine-based regenerative medicine company AiVita Biomedical Inc. feels good that it has a cash-generating beauty product arm to cushion clinical development of its cancer drug.

Duo Say They Take Nutritional Drinks to Next Level

Four-Product Juice Offering Targets Athletes

The cold-pressed juice market is saturated, which is why Mode Nutrition Chief Executive and co-founder Tammo Walter say it isn’t enough to offer only cold-pressed juices.

Prev